ADMA Biologics, Inc.

ADMA Biologics makes medicines derived from human blood plasma to treat people with weak immune systems and certain infectious diseases. Their main products are BIVIGAM and ASCENIV, which are intravenous immune globulin treatments given to patients who cannot produce enough antibodies on their own, and Nabi-HB, which is used after potential exposure to hepatitis B. The company operates its own blood plasma collection centers and sells its products through pharmacies and drug wholesalers.